Search results
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 4 hours agovaccine, Nuvaxovid. Since then, the stock has trended lower. The vaccine is based on protein...
FDA approves first RSV vaccine for use in at-risk adults over 50
The Hill· 5 days agoThe Food and Drug Administration (FDA) recently approved an expansion of a respiratory syncytial...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life Style via AOL· 4 hours agoSmith recommends that “if you do test positive, then you need to talk to a doctor about whether or...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 1 day agoPfizer is competing against GSK's Arexvy, which hit the market about the same time in 2023. Moderna...
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
CNBC· 6 days agoThe shot, called Arexvy, is the first vaccine cleared by the FDA to protect that population from...
FDA clears GSK's RSV vaccine for adults ages 50-59
United Press International via Yahoo News· 5 days agoThe U.S. Food and Drug Administration on Friday approved GSK's respiratory syncytial virus vaccine for high-risk adults ages 50 to 59, expanding the...
GSK's RSV Vaccine Arexvy Gets FDA Nod for Adults 50-59 Years
Zacks via Yahoo Finance· 3 days agoArexvy had an exceptional launch and generated...GSK expects Arexvy to generate more than £3 billion...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 1 day agoThe vaccine, dubbed...older adults it can be serious or even deadly. Moderna will rival Pfizer and...
Two shots in one? Moderna's COVID-19 and flu vaccine reports favorable results
USA Today· 4 days agoModerna said Monday that its combination vaccine against flu and COVID-19 drew a greater immune...
FDA Gives Nod to RSV Vaccine for People in Their 50s
US News & World Report· 3 days agoThe U.S. Food and Drug Administration on Friday has for the first time approved the use of a respiratory syncytial virus (RSV) vaccine for people in their ...